The $26. 7 Billion Cellular Expansion Market | Markets & Markets

CHICAGO, March 19, 2024 /PRNewswire/ — The cellular expansion through earnings market is estimated to be worth $14. 3 billion by 2024 and is expected to reach $26. 7 billion by 2029, growing at a CAGR of 13. 3% from 2024 to 2029, according to a new report by MarketsandMarkets. Some points that contribute to the expansion of the global market come with the expansion of investments in R

Download an illustrative preview: https://www. marketsandmarkets. com/pdfdownloadNew. asp?id=194978883

Explore in-depth content on the “Cell Expansion Market”

514 – Tables49 – Figures563 – Pages

Cell Expansion Market Scope:

Report Coverage

Details

Market Revenue in 2024

$14. 3 billion

Estimated until 2029

$26. 7 billion

Growth Rate

Growing at a CAGR of 13. 3%

Market length available for

2022-2029

Forecast Period

2024-2029

Forecast Units

Value (billions of U. S. dollars)

Report Coverage

Revenue Forecasts, Competitive Landscape, Growth Drivers, and Trends

Segments Covered

Product, mobile type, application and end user.

Geographies Covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Report Highlights

Up-to-Date Financial Information / Player Product Portfolio

Key Market Opportunities

Emerging Markets

Key Market Drivers

Increased occurrence of chronic diseases.

Consumables accounted for the largest percentage of the product in the Cell Expansion market in 2023.

On a product basis, the cell expansion market is segmented into consumables and equipment. The consumables segment dominated the market in 2023 and is expected to dominate the market during the forecast period. The consumables are then segmented into media, reagents, sera, containers, and other consumables. The largest percentage of this segment is attributed to the expansion of research activities for the progression of new biopharmaceuticals.

The biopharmaceutical production segment is estimated to register the highest expansion rate of the predicted era in the mobile expansion market.

On the basis of applications, the mobile expansion market is segmented into biopharmaceutical production, tissue engineering and regenerative medicine, drug detection and development, and other applications. The biopharmaceutical production segment is estimated to register the highest expansion rate during the forecast period. The production of biopharmaceuticals such as vaccines, monoclonal antibodies, and healing proteins, owing to the increasing occurrence of chronic diseases, is expected to drive the expansion of the biopharmaceutical production segment in the coming years.

The Asia-Pacific region is the fastest-growing region in the cell expansion market in 2023.

Based on region, the Cellular Expansion Market is segmented into primary regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The Asia-Pacific region is expected to record the fastest expansion in mobile expansion due to expanding study practices in the realm of complex treatments such as tissue engineering and regenerative medicine, major government investments, and investment in R

Request pattern pages: https://www. marketsandmarkets. com/requestpatternNew. asp?id=194978883

Cell Expansion Market Dynamics:

Drivers:

Restrictions:

Opportunities:

Challenge:

Key Players in the Cell Expansion Industry Market:

Key players in the cell expansion market include Thermo Fisher Scientific Inc. (USA), Danaher Corporation (USA), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (USA)Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (USA), Repligen Corporation (USA), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (USA), Stemcell Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (USA) and Eppendorf Laboratories (India). Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co. , Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (United States), ACROBiosystems (United States), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co. , Ltd. (China), Neuromics (USA), Bionet (Spain) and Cellexus (UK).

The interviews conducted for this report can be categorized as follows:

Recent Developments in the Cell Expansion Industry:

Get 10% free customization in this report: https://www. marketsandmarkets. com/requestCustomizationNew. asp?id=194978883

Cell Expansion Market: Key Benefits of Buying the Report:

The report will help the market leaders/new entrants by offering them the closest estimates to the profit figures for the entire Cell Expansion market and its sub-segments. It will also allow stakeholders to better perceive the competitive landscape and gain more information to better position their business and scale up appropriate market access strategies. This report will allow stakeholders to feel the pulse of the market and provide them with insights into key market drivers, restraints, opportunities, and challenging situations.

The report provides data on the following indicators:

Related Reports:

Lock Market: Global Forecast to 2028

3D Cell Culture Market: Global Forecast to 2028

Microcarrier Market: Global Forecast to 2028

Primary Cell Market: Global Forecast to 2028

Laboratory Centrifuges Market: Global Forecast to 2026

About Markets & Markets:

MarketsandMarkets has been identified as one of the best management consulting firms in the United States through Forbes, according to its report.

MarketsandMarkets is an oceanic option for expansion consulting and program management, leveraging a human-machine relationship to drive the supernatural expansion of progressive organizations in the B2B space. We have the broadest imaginable view of emerging technologies, which makes us talented at co-creating a supernatural expansion. for our customers.

Earlier this year, we made a formal transformation to become one of America’s most sensible control consulting firms, according to a survey conducted through Forbes.

The B2B economy is witnessing the emergence of $25 trillion in new profit streams that upgrade existing profit streams in this decade alone. We work with our clients on expansion programs, helping them monetize this $25 billion opportunity. Our Service Lines: TAM Expansion, Access Option. -Market Strategy (GTM) for execution, market percentage gain, account activation, and idea leadership marketing.

Based on the “GIVE Growth” principle, we work with several Forbes Global 2000 B2B companies, helping them remain applicable in a disruptive ecosystem. Our concepts and methods are shaped through our industry experts, an AI-powered market intelligence cloud, and years of experience. research. KnowledgeStore (our market intelligence cloud) integrates our research, facilitates interconnection research across a suite of applications, helping consumers take a look at the entire ecosystem and perceive the profit adjustments that are taking place in their industry.

For more information, visit www. MarketsandMarkets. com or follow us on Twitter, LinkedIn and Facebook.

Contact: Mr. Aashish MehraMarketsandMarkets INC. 630 Dundee RoadSuite 430Northbrook, IL 60062USA: 1-888-600-6441Email: sales@marketsandmarkets. comResearch Insights: https://www. marketsandmarkets. com/ResearchInsight/cell-expansion-market. aspVisitez our website: Content https://www. marketsandmarkets. com/Fuente: https://www. marketsandmarkets. com/PressReleases/cell-expansion. asp

Logo: https://mma. prnewswire. com/media/2297424/MarketsandMarkets_Logo. jpg

Show content: https://www. prnewswire. co. uk/news-releases/cell-expansion-market-worth-26-7-billion–marketsandmarkets-302092519. html

Leave a Comment

Your email address will not be published. Required fields are marked *